Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.20
Ask:
170.80
Spread: 0.60 (0.353%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

SThree: Upgrade to market expectations

23 Nov 2020 07:00

SThree (STEM) SThree: Upgrade to market expectations 23-Nov-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


23 November 2020

 

SThree plc

 

Upgrade to market expectations

 

 

SThree plc ("SThree" or the "Group"), the leading global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), is pleased to announce an upwards revision of its profit before tax expectations for the financial year 2020.

 

The Board has been encouraged by the increasing levels of activity it has seen during the quarter, despite continuing uncertainties surrounding the pandemic. There has been a notable improvement in the performance of the US and German businesses, with high levels of demand in Life Sciences and Technology through October and early November. As a result, the Group now expects profit before tax for the 12 months to 30 November 2020, after including the costs associated with the previously announced closure of the Australian business, to be marginally above the top end of the range of market expectations*.

 

SThree will announce its FY20 Trading Update on 14 December 2020.

 

Mark Dorman, CEO, commented:

 

"I am pleased to report that trading in the final quarter of the year is coming in ahead of expectations, with our purpose of "bringing skilled people together to build the future" and our strategy focused on STEM skills and flexible working continuing to serve us well. This performance has been driven by hard work and dedication from our teams throughout the business, alongside learning to operate better in whatever environment we are in. This has enabled us to capitalise on current opportunities and to continue to build a strong platform for the future. With this confidence in our purpose and strategy, we will continue to execute against our plans as we look to deliver the Group's long-term ambitions."

 

 

*Current Analyst PBT expectations range from £23.2m - £27.7m. Source: Reuters

 

- Ends -

 

 Enquiries:

 

 

 

 SThree plc

020 7268 6000

 Mark Dorman, Chief Executive Officer

 

 Alex Smith, Chief Financial Officer

 

 Steve Hornbuckle, Company Secretary

 

 

 Alma PR

020 3405 0205

 

 Rebecca Sanders-Hewett

 Susie Hudson

 

SThree@almapr.co.uk

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (Regulation (EU) No.596/2014).

 

 

Notes to editors

 

SThree plc brings skilled people together to build the future. It is the only global pure-play specialist staffing business focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), providing permanent and flexible contract talent to a diverse base of over 9,000 clients in 15 countries.

The Group's c.2,700 staff cover the Technology, Life Sciences, Engineering and Banking & Finance sectors.

 

SThree plc is quoted on the Premium Segment of the Official List of the FCA under the ticker symbol STEM and also has a US level one ADR facility, symbol SERTY. 

 

Important notice

 

Certain statements in this announcement are forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Certain data from the announcement is sourced from unaudited internal management information and is before any exceptional items. Accordingly, undue reliance should not be placed on forward looking statements.

 


ISIN:GB00B0KM9T71
Category Code:MSCM
TIDM:STEM
LEI Code:2138003NEBX5VRP3EX50
Sequence No.:88304
EQS News ID:1149783
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
5th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:25 pmRNSHolding(s) in Company
1st Jun 202612:29 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
26th May 20264:00 pmRNSHolding(s) in Company
26th May 20269:30 amRNSHolding(s) in Company
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
22nd May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
12th May 20265:16 pmRNSDirector/PDMR Shareholding
8th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:51 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20263:30 pmRNSHolding(s) in Company
29th Apr 202612:20 pmRNSResult of AGM
24th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 202610:35 amRNSHolding(s) in Company
14th Apr 202610:29 amRNSHolding(s) in Company
13th Apr 20264:45 pmRNSDirector/PDMR Shareholding
13th Apr 20263:38 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:14 pmRNSHolding(s) in Company
7th Apr 20269:30 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSTotal Voting Rights
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20262:37 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:37 pmRNSPurchase of shares into the EBT
17th Mar 20269:50 amRNSHolding(s) in Company
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:01 amRNSCFO departure and succession plan
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
17th Mar 20267:00 amRNSFY26 Q1 Trading Update
13th Mar 20263:30 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202611:00 amRNSAnnual Financial Report
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20264:37 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.